Fungal Prosthetic Joint Infection : A Case Series and Review of the Literature
© 2024. The Author(s)..
INTRODUCTION: Fungal prosthetic joint infections comprise less than 1% of prosthetic joint infections. Thus, little is known regarding optimal management. This study aims to characterize the microbiology, surgical and medical management, and outcomes for these complex infections. The objectives of this study were to assess the impact of surgical approach, antifungal treatment, fungal species, and time to onset of infection from initial surgery on patient outcomes.
METHODS: A retrospective record review over 12 years was performed in two health systems that included patients with a deep culture positive for a fungal isolate and the presence of a prosthetic joint. A literature review was performed using the same inclusion criteria. A total of 289 cases were identified and analyzed.
RESULTS: Candida was the most common isolate, and a two-stage revision was the most commonly employed surgical modality. The type of surgical intervention had a statistically significant relationship with outcome (P = 0.022).
CONCLUSIONS: Two-stage revision with extended antifungal therapy is preferred in these infections due to higher rates of positive outcomes.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Infectious diseases and therapy - (2024) vom: 13. Apr. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Starnes, Victoria [VerfasserIn] |
---|
Links: |
---|
Themen: |
Fungal |
---|
Anmerkungen: |
Date Revised 13.04.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1007/s40121-024-00964-9 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM371029384 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM371029384 | ||
003 | DE-627 | ||
005 | 20240415232444.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240415s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s40121-024-00964-9 |2 doi | |
028 | 5 | 2 | |a pubmed24n1375.xml |
035 | |a (DE-627)NLM371029384 | ||
035 | |a (NLM)38613628 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Starnes, Victoria |e verfasserin |4 aut | |
245 | 1 | 0 | |a Fungal Prosthetic Joint Infection |b A Case Series and Review of the Literature |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 13.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a © 2024. The Author(s). | ||
520 | |a INTRODUCTION: Fungal prosthetic joint infections comprise less than 1% of prosthetic joint infections. Thus, little is known regarding optimal management. This study aims to characterize the microbiology, surgical and medical management, and outcomes for these complex infections. The objectives of this study were to assess the impact of surgical approach, antifungal treatment, fungal species, and time to onset of infection from initial surgery on patient outcomes | ||
520 | |a METHODS: A retrospective record review over 12 years was performed in two health systems that included patients with a deep culture positive for a fungal isolate and the presence of a prosthetic joint. A literature review was performed using the same inclusion criteria. A total of 289 cases were identified and analyzed | ||
520 | |a RESULTS: Candida was the most common isolate, and a two-stage revision was the most commonly employed surgical modality. The type of surgical intervention had a statistically significant relationship with outcome (P = 0.022) | ||
520 | |a CONCLUSIONS: Two-stage revision with extended antifungal therapy is preferred in these infections due to higher rates of positive outcomes | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Fungal | |
650 | 4 | |a Orthopedic infections | |
650 | 4 | |a Prosthetic joint infection | |
700 | 1 | |a Duggan, Joan |e verfasserin |4 aut | |
700 | 1 | |a Hollingshead, Caitlyn |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Infectious diseases and therapy |d 2012 |g (2024) vom: 13. Apr. |w (DE-627)NLM240483693 |x 2193-8229 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:13 |g month:04 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40121-024-00964-9 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 13 |c 04 |